Versant Venture Capital Vi, L.P. is of Tempest Therapeutics, Inc.. Currently has a direct ownership of 209,941 shares of TPST, which is worth approximately $149,058. The most recent transaction as insider was on Aug 12, 2024, when has been sold 387,999 shares (Common Stock) at a price of $1.1 per share, resulting in proceeds of $426,798. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
n/a 12M change
Total Value Held $149,058

Versant Venture Capital VI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2024
SELL
Open market or private sale
$426,798 $1.1 p/Share
387,999 Reduced 64.89%
209,941 Common Stock
Aug 08 2024
SELL
Open market or private sale
$540,000 $1.35 p/Share
400,000 Reduced 40.08%
597,940 Common Stock

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
IPSC
Century Therapeutics, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
GRPH
Graphite Bio, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
VVC

Versant Venture Capital Vi, L.P.

San Francisco, CA

Track Institutional and Insider Activities on TPST

Follow Tempest Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPST shares.

Notify only if

Insider Trading

Get notified when an Tempest Therapeutics, Inc. insider buys or sells TPST shares.

Notify only if

News

Receive news related to Tempest Therapeutics, Inc.

Track Activities on TPST